Brice, Alexis
Hôpital Avicenne
48 papers on CoChatORCID 0000-0002-0941-3990
Most cited papers
- Verified
DNA repair pathways underlie a common genetic mechanism modulating onset in polyglutamine diseases
Bettencourt, C., Hensman‐Moss, D., Flower, M., Wiethoff, S., Brice, A., Goizet, C., Stevanin, G., Koutsis, G., Karadima, G., Panas, M., et al. (2016) · Annals of Neurology
Genetic Neurodegenerative DiseasesGenetic factors in colorectal cancer
Cited by 227
- Verified
Diagnosis of Parkinson's disease on the basis of clinical and genetic classification: a population-based modelling study
Nalls, M. A., McLean, C. Y., Rick, J., Eberly, S., Hutten, S. J., Gwinn, K., Sutherland, M., Martinez, M., Heutink, P., Williams, N. M., et al. (2015) · The Lancet Neurology
Parkinson's Disease Mechanisms and TreatmentsDementia and Cognitive Impairment Research
Cited by 204
- Verified
Convergent genetic and expression data implicate immunity in Alzheimer's disease
International Genomics of Alzheimer's Disease Consortium (IGAP), Jones, L., Lambert, J., Wang, L., Choi, S., Harold, D., Vedernikov, A., Escott‐Price, V., Stone, T., Richards, A., et al. (2015) · Alzheimer's & Dementia
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 199
- Verified
Using genome-wide complex trait analysis to quantify ‘missing heritability’ in Parkinson’s disease
Keller, M. F., Saad, M., Bras, J., Bettella, F., Nicolaou, N., Simon-Sanchez, J., Mittag, F., Buchel, F., Sharma, M., Gibbs, J. R., et al. (2012) · Human Molecular Genetics
Genetic Associations and EpidemiologyParkinson's Disease Mechanisms and Treatments
Cited by 190
- Verified
Demographic, neurological and behavioural characteristics and brain perfusion SPECT in frontal variant of frontotemporal dementia
Ber, I. L., Guedj, E., Gabelle, A., Verpillat, P., Volteau, M., Thomas-Anterion, C., Decousus, M., Hannequin, D., Vera, P., Lacomblez, L., et al. (2006) · Brain
Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments
Cited by 179
- Verified
C9orf72 repeat expansions are a rare genetic cause of parkinsonism
Lesage, S., Le Ber, I., Condroyer, C., Broussolle, E., Gabelle, A., Thobois, S., Pasquier, F., Mondon, K., Dion, P. A., Rochefort, D., et al. (2013) · Brain
Parkinson's Disease Mechanisms and TreatmentsAmyotrophic Lateral Sclerosis Research
Cited by 164
- Verified
LRRK2 impairs PINK1/Parkin-dependent mitophagy via its kinase activity: pathologic insights into Parkinson’s disease
Bonello, F., Hassoun, S.-M., Mouton-Liger, F., Shin, Y. S., Muscat, A., Tesson, C., Lesage, S., Beart, P. M., Brice, A., Krupp, J., et al. (2019) · Human Molecular Genetics
Parkinson's Disease Mechanisms and TreatmentsAutophagy in Disease and Therapy
Cited by 163
- Verified
Parkin deficiency modulates NLRP 3 inflammasome activation by attenuating an A 20‐dependent negative feedback loop
Mouton‐Liger, F., Rosazza, T., Sepulveda‐Diaz, J., Ieang, A., Hassoun, S., Claire, E., Mangone, G., Brice, A., Michel, P. P., Corvol, J., et al. (2018) · Glia
Inflammasome and immune disordersParkinson's Disease Mechanisms and Treatments
Cited by 160
- Verified
Implication of the Immune System in Alzheimer's Disease: Evidence from Genome-Wide Pathway Analysis
Lambert, J.-C., Grenier-Boley, B., Chouraki, V., Heath, S., Zelenika, D., Fievet, N., Hannequin, D., Pasquier, F., Hanon, O., Brice, A., et al. (2010) · Journal of Alzheimer's Disease
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 144
- Verified
Temporal order of clinical and biomarker changes in familial frontotemporal dementia
Staffaroni, A. M., Quintana, M., Wendelberger, B., Heuer, H. W., Russell, L. L., Cobigo, Y., Wolf, A., Goh, S.-Y. M., Petrucelli, L., Gendron, T. F., et al. (2022) · Nature Medicine
Dementia and Cognitive Impairment ResearchAmyotrophic Lateral Sclerosis Research
Cited by 140
- Verified
Identification of evolutionarily conserved gene networks mediating neurodegenerative dementia
Swarup, V., Hinz, F. I., Rexach, J. E., Noguchi, K.-I., Toyoshiba, H., Oda, A., Hirai, K., Sarkar, A., Seyfried, N. T., Cheng, C., et al. (2019) · Nature Medicine
Alzheimer's disease research and treatmentsBioinformatics and Genomic Networks
Cited by 136
- Verified
Genome-wide survival study identifies a novel synaptic locus and polygenic score for cognitive progression in Parkinson’s disease
Liu, G., Peng, J., Liao, Z., Locascio, J. J., Corvol, J.-C., Zhu, F., Dong, X., Maple-Grødem, J., Campbell, M. C., Elbaz, A., et al. (2021) · Nature Genetics
Parkinson's Disease Mechanisms and TreatmentsGenetic Associations and Epidemiology
Cited by 127
- Verified
RAB32 Ser71Arg in autosomal dominant Parkinson's disease: linkage, association, and functional analyses
Gustavsson, E. K., Follett, J., Trinh, J., Barodia, S. K., Real, R., Liu, Z., Grant-Peters, M., Fox, J. D., Appel-Cresswell, S., Stoessl, A. J., et al. (2024) · The Lancet Neurology
Parkinson's Disease Mechanisms and TreatmentsNuclear Receptors and Signaling
Cited by 114
- Verified
Mutations in DCC cause isolated agenesis of the corpus callosum with incomplete penetrance
Marsh, A. P. L., Heron, D., Edwards, T. J., Quartier, A., Galea, C., Nava, C., Rastetter, A., Moutard, M.-L., Anderson, V., Bitoun, P., et al. (2017) · Nature Genetics
Fetal and Pediatric Neurological DisordersGenetics and Neurodevelopmental Disorders
Cited by 101
- Verified
Homozygous GRN mutations: new phenotypes and new insights into pathological and molecular mechanisms
Huin, V., Barbier, M., Bottani, A., Lobrinus, J. A., Clot, F., Lamari, F., Chat, L., Rucheton, B., Fluchère, F., Auvin, S., et al. (2020) · Brain
Lysosomal Storage Disorders ResearchAmyotrophic Lateral Sclerosis Research
Cited by 96
- Verified
Sqstm1 knock-down causes a locomotor phenotype ameliorated by rapamycin in a zebrafish model of ALS/FTLD
Lattante, S., de Calbiac, H., Le Ber, I., Brice, A., Ciura, S., & Kabashi, E. (2015) · Human Molecular Genetics
Amyotrophic Lateral Sclerosis ResearchHereditary Neurological Disorders
Cited by 90
- Verified
Genetic evaluation of dementia with Lewy bodies implicates distinct disease subgroups
Kaivola, K., Shah, Z., Chia, R., International LBD Genomics Consortium, Black, S. E., Gan-Or, Z., Keith, J., Masellis, M., Rogaeva, E., Brice, A., et al. (2022) · Brain
Parkinson's Disease Mechanisms and TreatmentsDementia and Cognitive Impairment Research
Cited by 65
- Verified
Additional rare variant analysis in Parkinson’s disease cases with and without known pathogenic mutations: Evidence for oligogenic inheritance
Lubbe, S. J., Escott-Price, V., Gibbs, J. R., Nalls, M. A., Bras, J., Price, T. R., Nicolas, A., Jansen, I. E., Mok, K. Y., Pittman, A. M., et al. (2016) · Human Molecular Genetics
Parkinson's Disease Mechanisms and TreatmentsLysosomal Storage Disorders Research
Cited by 61
- Verified
Mutations in UBQLN2 are rare in French amyotrophic lateral sclerosis
Millecamps, S., Corcia, P., Cazeneuve, C., Boillée, S., Seilhean, D., Danel-Brunaud, V., Vandenberghe, N., Pradat, P.-F., Le Forestier, N., Lacomblez, L., et al. (2012) · Neurobiology of Aging
Amyotrophic Lateral Sclerosis ResearchHereditary Neurological Disorders
Cited by 40
- Verified
Differential impairment of cerebrospinal fluid synaptic biomarkers in the genetic forms of frontotemporal dementia
Sogorb-Esteve, A., Nilsson, J., Swift, I. J., Heller, C., Bocchetta, M., Russell, L. L., Peakman, G., Convery, R. S., van Swieten, J. C., Seelaar, H., et al. (2022) · Alzheimer's Research & Therapy
Amyotrophic Lateral Sclerosis ResearchAlzheimer's disease research and treatments
Cited by 39
- Verified
Meta-analysis of genetic association with diagnosed Alzheimer’s disease identifies novel risk loci and implicates Abeta, Tau, immunity and lipid processing
Kunkle, B., Grenier-Boley, B., Sims, R., Bis, J., Naj, A., Boland, A., Vronskaya, M., van der Lee, S., Amlie-Wolf, A., Bellenguez, C., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory)
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 35
- Verified
Genome-wide determinants of mortality and motor progression in Parkinson’s disease
Tan, M. M. X., Lawton, M. A., Pollard, M. I., Brown, E., Real, R., Carrasco, A. M., Bekadar, S., Jabbari, E., Reynolds, R. H., Iwaki, H., et al. (2024) · npj Parkinson's Disease
Parkinson's Disease Mechanisms and TreatmentsGenetic Associations and Epidemiology
Cited by 17
- Verified
Examining empathy deficits across familial forms of frontotemporal dementia within the GENFI cohort
Foster, P. H., Russell, L. L., Peakman, G., Convery, R. S., Bouzigues, A., Greaves, C. V., Bocchetta, M., Cash, D. M., van Swieten, J. C., Jiskoot, L. C., et al. (2022) · Cortex
Dementia and Cognitive Impairment ResearchAmyotrophic Lateral Sclerosis Research
Cited by 16
- Verified
Multi-cohort machine learning identifies predictors of cognitive impairment in Parkinson’s disease
Loo, R. T. J., Pavelka, L., Mangone, G., Khoury, F., Vidailhet, M., Corvol, J.-C., Glaab, E., On behalf of the NCER-PD Consortium, Acharya, G., Aguayo, G., et al. (2025) · npj Digital Medicine
Parkinson's Disease Mechanisms and TreatmentsDementia and Cognitive Impairment Research
Cited by 9
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free